In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to 2021

Table of Contents

1 INTRODUCTION 20

1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 23

2 RESEARCH METHODOLOGY 24

2.1 RESEARCH DATA 24
2.1.1 SECONDARY DATA 25
2.1.1.1 Key data from secondary sources 25
2.1.2 PRIMARY DATA 26
2.1.2.1 Key data from primary sources 26
2.1.2.2 Key industry insights 27
2.2 MARKET SIZE ESTIMATION 27
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.4 MARKET SHARE ESTIMATION 30
2.5 ASSUMPTIONS FOR THE STUDY 30

3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 40

4.1 IN VITRO DIAGNOSTICS (IVD): MARKET OVERVIEW 40
4.2 ASIA-PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES 41
4.3 GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET 42
4.4 GEOGRAPHIC MIX: IN VITRO DIAGNOSTICS MARKET 43
4.5 IN VITRO DIAGNOSTICS MARKET: DEVELOPING VS. DEVELOPED MARKETS 44

5 MARKET OVERVIEW 45

5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 47
5.2.1 MARKET DRIVERS 48
5.2.1.1 Rising incidence of chronic lifestyle diseases 48
5.2.1.2 Increasing adoption of point-of-care testing 50
5.2.1.3 Growing awareness of personalized medicine 50
5.2.1.4 Growth in the number of private diagnostic centers 51
5.2.2 MARKET RESTRAINTS 52
5.2.2.1 Inadequate reimbursement 52
5.2.2.2 Rising healthcare costs and low budgets 52
5.2.3 MARKET OPPORTUNITIES 53
5.2.3.1 Introduction of a new range of condition-specific markers and tests with advances in genomics and proteomics 53
5.2.3.2 Emerging economies with increasing investments 53
5.2.3.3 Growing significance of companion diagnostics 54
5.2.4 MARKET CHALLENGES 54
5.2.4.1 Stringent regulatory framework 54
5.2.4.2 Operational barriers for the use of diagnostic tests 55

6 INDUSTRY INSIGHTS 56

6.1 INTRODUCTION 56
6.2 INDUSTRY TRENDS 56
6.2.1 AUTOMATION OF CLINICAL LABORATORY TECHNIQUES 57
6.2.2 MICROFLUIDICS-BASED POC AND LOC DIAGNOSTIC DEVICES FOR LABORATORY TESTING 57
6.2.3 RISE IN REAGENT RENTAL AGREEMENTS 58
6.3 REGULATORY OVERVIEW 58
6.3.1 NORTH AMERICA 58
6.3.1.1 U.S. 58
6.3.1.2 Canada 59
6.3.2 EUROPE 60
6.3.3 ASIA-PACIFIC 62
6.3.3.1 Japan 62
6.3.3.2 China 63
6.3.3.3 India 63

7 GLOBAL IVD MARKET, BY PRODUCT & SERVICE 65

7.1 INTRODUCTION 66
7.2 REAGENTS & KITS 67
7.3 INSTRUMENTS 68
7.4 DATA MANAGEMENT SOFTWARE 70
7.5 SERVICES 71

8 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 74

8.1 INTRODUCTION 75
8.2 IMMUNOCHEMISTRY/IMMUNOASSAYS 76
8.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 78
8.2.1.1 Chemiluminescence immunoassays (CLIAS) 80
8.2.1.2 Fluorescence immunoassays (FIAS) 81
8.2.1.3 Colorimetric immunoassays (CIS) 83
8.2.2 RADIOIMMUNOASSAY (RIA) 84
8.2.3 RAPID TESTS 85
8.2.4 WESTERN BLOT 86
8.2.5 ENZYME-LINKED IMMUNOSPOT (ELISPOT) ASSAY 87
8.3 CLINICAL CHEMISTRY 88
8.3.1 BASIC METABOLIC PANEL 90
8.3.2 ELECTROLYTE PANEL 91
8.3.3 LIVER PANEL 92
8.3.4 LIPID PROFILE 93
8.3.5 RENAL PROFILE 94
8.3.6 THYROID FUNCTION PANEL 95
8.3.7 SPECIALTY CHEMICAL TESTS 97
8.4 MOLECULAR DIAGNOSTICS (MDX) 98
8.4.1 POLYMERASE CHAIN REACTION (PCR) 99
8.4.2 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) 100
8.4.3 MICROARRAY 101
8.4.4 HYBRIDIZATION 103
8.4.5 DNA SEQUENCING & NEXT-GENERATION SEQUENCING 104
8.4.6 OTHER MDX TECHNOLOGIES 106
8.5 CLINICAL MICROBIOLOGY 107
8.6 HEMATOLOGY 109
8.7 COAGULATION AND HEMOSTASIS 111
8.8 OTHER IVD TECHNOLOGIES 113

9 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION 114

9.1 INTRODUCTION 115
9.2 DIABETES 116
9.3 INFECTIOUS DISEASES 118
9.4 ONCOLOGY/CANCER 120
9.5 CARDIOLOGY 122
9.6 NEPHROLOGY 123
9.7 AUTOIMMUNE DISEASES 125
9.8 DRUG TESTING/PHARMACOGENOMICS 126
9.9 HIV/AIDS 128
9.10 OTHER APPLICATIONS 130

10 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY END USER 132

10.1 INTRODUCTION 133
10.2 HOSPITALS 134
10.3 LABORATORIES 135
10.4 POINT-OF-CARE TESTING 137
10.5 PATIENT SELF-TESTING 138
10.6 ACADEMIC INSTITUTES 139
10.7 OTHER END USERS 141

11 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY REGION 142

11.1 INTRODUCTION 143
11.2 NORTH AMERICA 145
11.2.1 U.S. 149
11.2.2 CANADA 152
11.3 EUROPE 155
11.3.1 GERMANY 160
11.3.2 FRANCE 163
11.3.3 U.K. 166
11.3.4 ITALY 169
11.3.5 SPAIN 172
11.3.6 RUSSIA 174
11.3.7 REST OF EUROPE (ROE) 177
11.4 ASIA-PACIFIC (APAC) 179
11.4.1 JAPAN 183
11.4.2 CHINA 186
11.4.3 INDIA 189
11.4.4 REST OF ASIA-PACIFIC (ROAPAC) 192
11.5 LATIN AMERICA 194
11.5.1 BRAZIL 197
11.5.2 MEXICO 200
11.5.3 REST OF LATIN AMERICA (ROLA) 202
11.6 MIDDLE EAST AND AFRICA 204

12 COMPETITIVE LANDSCAPE 207

12.1 OVERVIEW 207
12.2 MARKET SHARE ANALYSIS 208
12.3 COMPETITIVE SITUATION AND TRENDS 209
12.4 NEW PRODUCT LAUNCHES 210
12.5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 211
12.6 ACQUISITIONS 212
12.7 EXPANSIONS 213
12.8 OTHER STRATEGIES 214
 

13 COMPANY PROFILES 215

(Overview, Products and Services, Financials, Strategy & Development)*
13.1 INTRODUCTION 215
13.2 ABBOTT LABORATORIES, INC. 216
13.3 BECTON, DICKINSON AND COMPANY 219
13.4 BIOMÉRIEUX SA 223
13.5 BIO-RAD LABORATORIES, INC. 227
13.6 DANAHER CORPORATION 232
13.7 JOHNSON & JOHNSON 238
13.8 ROCHE DIAGNOSTICS 241
13.9 SIEMENS AG 246
13.10 SYSMEX CORPORATION 252
13.11 THERMO FISHER SCIENTIFIC, INC. 257
13.12 ORTHO-CLINICAL DIAGNOSTICS, INC. 262
13.13 QIAGEN N.V. 264
13.14 DIASORIN S.P.A. 268
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
14 APPENDIX 275

LIST OF TABLES

TABLE 1 GLOBAL IVD MARKET SNAPSHOT 31
TABLE 2 NUMBER OF PEOPLE WITH DIABETES, BY REGION,
2015 VS. 2040 (MILLION INDIVIDUALS) 49
TABLE 3 IMPACT ANALYSIS: MARKET DRIVERS 51
TABLE 4 IMPACT ANALYSIS: MARKET RESTRAINTS 52
TABLE 5 IMPACT ANALYSIS: MARKET OPPORTUNITIES 54
TABLE 6 IMPACT ANALYSIS: MARKET CHALLENGES 55
TABLE 7 U.S.: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES 58
TABLE 8 U.S.: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 59
TABLE 9 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 60
TABLE 10 EUROPE: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES 60
TABLE 11 EUROPE: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 61
TABLE 12 JAPAN: CLASSIFICATION OF IVD DEVICES 62
TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 62
TABLE 14 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 63
TABLE 15 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 64
TABLE 16 GLOBAL IVD MARKET, BY PRODUCT & SERVICE, 2014–2021 (USD MILLION) 66
TABLE 17 GLOBAL IVD REAGENTS & KITS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 67
TABLE 18 GLOBAL IVD REAGENTS & KITS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 68
TABLE 19 GLOBAL IVD INSTRUMENTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 69
TABLE 20 GLOBAL IVD INSTRUMENTS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 69
TABLE 21 GLOBAL IVD DATA MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 70
TABLE 22 GLOBAL IVD DATA MANAGEMENT SOFTWARE MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 71
TABLE 23 GLOBAL IVD SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 72
TABLE 24 GLOBAL IVD SERVICES MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 73
TABLE 25 GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 75
TABLE 26 GLOBAL IMMUNOASSAY/IMMUNOCHEMISTRY MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 77
TABLE 27 GLOBAL IVD MARKET SIZE FOR IMMUNOCHEMISTRY/IMMUNOASSAY,
BY COUNTRY, 2014–2021 (USD MILLION) 77
TABLE 28 GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 79
TABLE 29 GLOBAL ELISA MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 79
TABLE 30 GLOBAL CHEMILUMINESCENCE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 81
TABLE 31 GLOBAL FLUORESCENCE IMMUNOASSAYS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 82
TABLE 32 GLOBAL COLORIMETRIC IMMUNOASSAYS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 83
TABLE 33 GLOBAL RADIOIMMUNOASSAY MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 85
TABLE 34 GLOBAL RAPID TESTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 86
TABLE 35 GLOBAL WESTERN BLOT MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 87
TABLE 36 GLOBAL ELISPOT ASSAY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 88
TABLE 37 GLOBAL IVD MARKET SIZE FOR CLINICAL CHEMISTRY, BY COUNTRY,
2014–2021 (USD MILLION) 89
TABLE 38 GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY TEST TYPE,
2014–2021 (USD MILLION) 90
TABLE 39 GLOBAL BASIC METABOLIC PANEL MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 91
TABLE 40 GLOBAL ELECTROLYTE PANEL MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 92
TABLE 41 GLOBAL LIVER PANEL MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 93
TABLE 42 GLOBAL LIPID PROFILE MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 94
TABLE 43 GLOBAL RENAL PROFILE MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 95
TABLE 44 GLOBAL THYROID FUNCTION PANEL MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 96
TABLE 45 GLOBAL SPECIALTY CHEMICAL TESTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 97
TABLE 46 GLOBAL IVD MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY,
2014–2021 (USD MILLION) 98
TABLE 47 GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 99
TABLE 48 GLOBAL PCR MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY,
2014–2021 (USD MILLION) 100
TABLE 49 GLOBAL INAAT MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2014–2021 (USD MILLION) 101
TABLE 50 GLOBAL MICROARRAY MARKET SIZE FOR MOLECULAR DIAGNOSTICS,
BY COUNTRY, 2014–2021 (USD MILLION) 102
TABLE 51 GLOBAL HYBRIDIZATION MARKET SIZE FOR MOLECULAR DIAGNOSTICS,
BY COUNTRY, 2014–2021 (USD MILLION) 103
TABLE 52 GLOBAL DNA SEQUENCING & NGS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2014–2021 (USD MILLION) 105
TABLE 53 GLOBAL OTHER MDX TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 106
TABLE 54 GLOBAL IVD MARKET SIZE FOR CLINICAL MICROBIOLOGY, BY COUNTRY,
2014–2021 (USD MILLION) 108
TABLE 55 GLOBAL IVD MARKET SIZE FOR HEMATOLOGY, BY COUNTRY,
2014–2021 (USD MILLION) 110
TABLE 56 GLOBAL IVD MARKET SIZE FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2014–2021 (USD MILLION) 112
TABLE 57 GLOBAL OTHER IVD TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 113
TABLE 58 GLOBAL IVD MARKET SIZE, BY APPLICATION, 2014 – 2021 (USD MILLION) 115
TABLE 59 GLOBAL DIABETIC PATIENT POPULATION IN 2015 AND 2040 (MILLION) 116
TABLE 60 GLOBAL IVD MARKET SIZE FOR DIABETES, BY COUNTRY,
2014–2021 (USD MILLION) 117
TABLE 61 GLOBAL IVD MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY,
2014–2021 (USD MILLION) 119
TABLE 62 U.S.: CANCER INCIDENCE RATE, BY REGION (PER 100,000 INDIVIDUALS)
2008-2012 120
TABLE 63 GLOBAL IVD MARKET SIZE FOR ONCOLOGY/CANCER, BY COUNTRY,
2014–2021 (USD MILLION) 121
TABLE 64 GLOBAL IVD MARKET SIZE FOR CARDIOLOGY, BY COUNTRY,
2014–2021 (USD MILLION) 123
TABLE 65 GLOBAL IVD MARKET SIZE FOR NEPHROLOGY, BY COUNTRY,
2014–2021 (USD MILLION) 124
TABLE 66 GLOBAL IVD MARKET SIZE FOR AUTOIMMUNE DISEASES, BY COUNTRY,
2014–2021 (USD MILLION) 126
TABLE 67 GLOBAL IVD MARKET SIZE FOR DRUG TESTING/PHARMACOGENOMICS,
BY COUNTRY, 2014–2021 (USD MILLION) 127
TABLE 68 GLOBAL IVD MARKET SIZE FOR HIV/AIDS, BY COUNTRY,
2014–2021 (USD MILLION) 129
TABLE 69 GLOBAL IVD MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY,
2014–2021 (USD MILLION) 131
TABLE 70 GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 134
TABLE 71 GLOBAL IVD MARKET SIZE FOR HOSPITALS, BY COUNTRY,
2014–2021 (USD MILLION) 135
TABLE 72 GLOBAL IVD MARKET SIZE FOR LABORATORIES, BY COUNTRY,
2014–2021 (USD MILLION) 136
TABLE 73 GLOBAL IVD MARKET SIZE FOR POC TESTING, BY COUNTRY,
2014–2021 (USD MILLION) 138
TABLE 74 GLOBAL IVD MARKET SIZE FOR PATIENT SELF-TESTING, BY COUNTRY,
2014–2021 (USD MILLION) 139
TABLE 75 GLOBAL IVD MARKET SIZE FOR ACADEMIC INSTITUTES, BY COUNTRY,
2014–2021 (USD MILLION) 140
TABLE 76 GLOBAL IVD MARKET SIZE FOR OTHER END USERS, BY COUNTRY,
2014–2021 (USD MILLION) 141
TABLE 77 GLOBAL IVD MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 144
TABLE 78 GLOBAL IVD MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 145
TABLE 79 NORTH AMERICA: IVD MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 146
TABLE 80 NORTH AMERICA: IVD MARKET SIZE, BY PRODUCT & SERVICE,
2014–2021 (USD MILLION) 147
TABLE 81 NORTH AMERICA: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 147
TABLE 82 NORTH AMERICA: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 148
TABLE 83 NORTH AMERICA: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 148
TABLE 84 U.S.: MACROECONOMIC INDICATORS 150
TABLE 85 U.S.: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014–2021 (USD MILLION) 150
TABLE 86 U.S.: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 151
TABLE 87 U.S.: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 151
TABLE 88 U.S.: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 152
TABLE 89 CANADA: MACROECONOMIC INDICATORS 153
TABLE 90 CANADA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014–2021 (USD MILLION) 153
TABLE 91 CANADA: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 154
TABLE 92 CANADA: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 154
TABLE 93 CANADA: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 155
TABLE 94 EUROPE: IVD MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 156
TABLE 95 EUROPE: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014–2021 (USD MILLION) 158
TABLE 96 EUROPE: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 158
TABLE 97 EUROPE: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 159
TABLE 98 EUROPE: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 159
TABLE 99 GERMANY: MACROECONOMIC INDICATORS 161
TABLE 100 GERMANY: IVD MARKET SIZE, BY PRODUCT & SERVICE,
2014–2021 (USD MILLION) 161
TABLE 101 GERMANY: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 162
TABLE 102 GERMANY: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 162
TABLE 103 GERMANY: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 163
TABLE 104 FRANCE: MACROECONOMIC INDICATORS 164
TABLE 105 FRANCE: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014–2021 (USD MILLION) 164
TABLE 106 FRANCE: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 165
TABLE 107 FRANCE: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 165
TABLE 108 FRANCE: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 166
TABLE 109 U.K.: MACROECONOMIC INDICATORS 167
TABLE 110 U.K.: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014–2021 (USD MILLION) 167
TABLE 111 U.K.: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 168
TABLE 112 U.K.: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 168
TABLE 113 U.K.: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 169
TABLE 114 ITALY: MACROECONOMIC INDICATORS 169
TABLE 115 ITALY: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014–2021 (USD MILLION) 170
TABLE 116 ITALY: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 170
TABLE 117 ITALY: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 171
TABLE 118 ITALY: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 171
TABLE 119 SPAIN: MACROECONOMIC INDICATORS 172
TABLE 120 SPAIN: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014–2021 (USD MILLION) 172
TABLE 121 SPAIN: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 173
TABLE 122 SPAIN: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 173
TABLE 123 SPAIN: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 174
TABLE 124 RUSSIA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014–2021 (USD MILLION) 175
TABLE 125 RUSSIA: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 175
TABLE 126 RUSSIA: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 176
TABLE 127 RUSSIA: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 176
TABLE 128 ROE: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014–2021 (USD MILLION) 177
TABLE 129 ROE: IVD MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 177
TABLE 130 ROE: IVD MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 178
TABLE 131 ROE: IVD MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 178
TABLE 132 APAC: IVD MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 181
TABLE 133 APAC: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION) 181
TABLE 134 APAC: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 182
TABLE 135 APAC: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 182
TABLE 136 APAC: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 183
TABLE 137 JAPAN: MACROECONOMIC INDICATORS 184
TABLE 138 JAPAN: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION) 184
TABLE 139 JAPAN: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 185
TABLE 140 JAPAN: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 185
TABLE 141 JAPAN: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 186
TABLE 142 CHINA: MACROECONOMIC INDICATORS 187
TABLE 143 CHINA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION) 187
TABLE 144 CHINA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 188
TABLE 145 CHINA: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 188
TABLE 146 CHINA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 189
TABLE 147 INDIA: MACROECONOMIC INDICATORS 190
TABLE 148 INDIA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION) 190
TABLE 149 INDIA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 191
TABLE 150 INDIA: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 191
TABLE 151 INDIA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 192
TABLE 152 ROAPAC: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION) 192
TABLE 153 ROAPAC: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 193
TABLE 154 ROAPAC: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 193
TABLE 155 ROAPAC: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 194
TABLE 156 LATIN AMERICA: IVD MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 195
TABLE 157 LATIN AMERICA: IVD MARKET SIZE, BY PRODUCT & SERVICE,
2014-2021 (USD MILLION) 195
TABLE 158 LATIN AMERICA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 196
TABLE 159 LATIN AMERICA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2021 (USD MILLION) 196
TABLE 160 LATIN AMERICA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 197
TABLE 161 BRAZIL: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION) 198
TABLE 162 BRAZIL: IVD MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 198
TABLE 163 BRAZIL: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 199
TABLE 164 BRAZIL: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 199
TABLE 165 MEXICO: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION) 200
TABLE 166 MEXICO: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 201
TABLE 167 MEXICO: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 201
TABLE 168 MEXICO: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 202
TABLE 169 ROLA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION) 202
TABLE 170 ROLA: IVD MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 203
TABLE 171 ROLA: IVD MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 203
TABLE 172 ROLA: IVD MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 204
TABLE 173 MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY PRODUCT & SERVICE,
2014-2021 (USD MILLION) 205
TABLE 174 MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 205
TABLE 175 MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY TECHNOLOGY,
2014-2021 (USD MILLION) 206
TABLE 176 MIDDLE EAST AND AFRICA: IVD MARKET SIZE, BY END USER,
2014-2021 (USD MILLION) 206
TABLE 177 NEW PRODUCT LAUNCHES, 2013–2016 210
TABLE 178 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016 211
TABLE 179 ACQUISITIONS, 2013–2016 212
TABLE 180 EXPANSIONS, 2013–2016 213
TABLE 181 OTHER DEVELOPMENTS, 2013–2016 214

LIST OF FIGURES

FIGURE 1 GLOBAL IN VITRO DIAGNOSTICS MARKET 21
FIGURE 2 RESEARCH DESIGN 24
FIGURE 3 BOTTOM-UP APPROACH 28
FIGURE 4 TOP-DOWN APPROACH 28
FIGURE 5 DATA TRIANGULATION METHODOLOGY 29
FIGURE 6 GLOBAL IVD MARKET SIZE, BY PRODUCTS & SERVICES,
2016 VS. 2021 (USD MILLION) 32
FIGURE 7 GLOBAL IVD MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION) 33
FIGURE 8 GLOBAL IVD MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION) 34
FIGURE 9 GLOBAL IMMUNOASSAY/IMMUNOCHEMISTRY MARKET SIZE, BY TYPE,
2016 VS. 2021 (USD MILLION) 35
FIGURE 10 GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY TYPE,
2016 VS. 2021 (USD MILLION) 36
FIGURE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE,
2016 VS. 2021 (USD MILLION) 37
FIGURE 12 GLOBAL IVD MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION) 38
FIGURE 13 GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET 39
FIGURE 14 RISING INCIDENCE OF CHRONIC LIFESTYLE DISEASES IS DRIVING GROWTH OF THE IN VITRO DIAGNOSTICS MARKET 40
FIGURE 15 REAGENTS & KITS COMMANDED THE LARGEST SHARE IN 2015 41
FIGURE 16 THE U.S. ACCOUNTED FOR LARGEST SHARE OF THE IN VITRO DIAGNOSTICS MARKET IN 2015 42
FIGURE 17 APAC TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 43
FIGURE 18 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH DURING THE FORECAST PERIOD 44
FIGURE 19 IVD MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
FIGURE 20 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN THE U.S.
(MILLION INDIVIDUALS) 49
FIGURE 21 MAJOR TRENDS IN THE IVD MARKET 56
FIGURE 22 CANADA: REGULATORY PROCESS FOR IVD DEVICES 59
FIGURE 23 EUROPE: REGULATORY PROCESS FOR IVD DEVICES 61
FIGURE 24 INDIA: REGULATORY PROCESS FOR IVD DEVICES 64
FIGURE 25 REAGENTS & KITS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 66
FIGURE 26 MOLECULAR DIAGNOSTICS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 75
FIGURE 27 ONCOLOGY, THE FASTEST-GROWING APPLICATION SEGMENT OF THE IVD MARKET 115
FIGURE 28 GLOBAL HIV POPULATION (2010-2015) 128
FIGURE 29 GLOBAL IN VITRO DIAGNOSTICS MARKET SIZE, BY END USER,
2016 VS. 2021 (USD MILLION) 133
FIGURE 30 GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA-PACIFIC ARE EMERGING GROWTH HOTSPOTS 143
FIGURE 31 GLOBAL IVD MARKET SHARE, BY REGION, 2015 VS. 2021 144
FIGURE 32 NORTH AMERICA: IVD MARKET SNAPSHOT 146
FIGURE 33 U.S.: CHRONIC DISEASES PREVALENCE (1995-2030) 149
FIGURE 34 EUROPE: IVD MARKET SNAPSHOT 157
FIGURE 35 APAC: IVD MARKET SNAPSHOT 180
FIGURE 36 PLAYERS MAJORLY ADOPTED THE STRATEGY OF PRODUCT LAUNCH FROM
2013 TO 2016 207
FIGURE 37 GLOBAL IN VITRO DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 208
FIGURE 38 BATTLE FOR MARKET SHARE: PRODUCT LAUNCH WAS THE KEY STRATEGY 209
FIGURE 39 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS 215
FIGURE 40 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT 216
FIGURE 41 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 219
FIGURE 42 BIOMÉRIEUX SA: COMPANY SNAPSHOT 223
FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 227
FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT 232
FIGURE 45 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 238
FIGURE 46 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 241
FIGURE 47 SIEMENS AG: COMPANY SNAPSHOT 246
FIGURE 48 SYSMEX CORPORATION: COMPANY SNAPSHOT 252
FIGURE 49 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 257
FIGURE 50 QIAGEN N.V.: COMPANY SNAPSHOT 264
FIGURE 51 DIASORIN S.P.A.: COMPANY SNAPSHOT 268

当レポートのプレスリリースは発行されておりません。